Generex Biotechnology Corporation (GNBT)
Create an Alert
0.0398
+0.00 +0.00%
OTCBB
Jun 17, 8:00PM
Delayed by 15 min
Currency in USD
Generex Biotechnology Corporation Revenue Quarterly:
0.00 for April 30, 2013Generex Biotechnology Corporation Historical Revenue Quarterly Data
Pro Data Export
Dates:
to
There is no data for the selected date range.
| Data for this Date Range | |
|---|---|
| April 30, 2013 | 0.00 |
| Jan. 31, 2013 | 0.00 |
| Oct. 31, 2012 | 0.00 |
| July 31, 2012 | 0.0067M |
| April 30, 2012 | 0.007M |
| Jan. 31, 2012 | 0.005M |
| Oct. 31, 2011 | 0.0099M |
| July 31, 2011 | 0.0225M |
| April 30, 2011 | 0.0656M |
| Jan. 31, 2011 | 0.0296M |
| Oct. 31, 2010 | 0.1739M |
| July 31, 2010 | 0.316M |
| April 30, 2010 | 0.3277M |
| Jan. 31, 2010 | 0.4313M |
| Oct. 31, 2009 | 0.0975M |
| July 31, 2009 | 0.1003M |
| April 30, 2009 | 0.0453M |
| Jan. 31, 2009 | 0.4346M |
| Oct. 31, 2008 | 0.5383M |
| July 31, 2008 | 0.06M |
| April 30, 2008 | Go Pro |
| Jan. 31, 2008 | Go Pro |
| Oct. 31, 2007 | Go Pro |
| July 31, 2007 | Go Pro |
| April 30, 2007 | Go Pro |
| Jan. 31, 2007 | Go Pro |
| Oct. 31, 2006 | Go Pro |
| July 31, 2006 | Go Pro |
| April 30, 2006 | Go Pro |
| Jan. 31, 2006 | Go Pro |
| Oct. 31, 2005 | Go Pro |
| July 31, 2005 | Go Pro |
| April 30, 2005 | Go Pro |
| Jan. 31, 2005 | Go Pro |
| Oct. 31, 2004 | Go Pro |
| July 31, 2004 | Go Pro |
| April 30, 2004 | Go Pro |
| Jan. 31, 2004 | Go Pro |
| Oct. 31, 2003 | Go Pro |
| July 31, 2003 | Go Pro |
| April 30, 2003 | Go Pro |
| Jan. 31, 2003 | Go Pro |
| Oct. 31, 2002 | Go Pro |
| July 31, 2002 | Go Pro |
| April 30, 2002 | Go Pro |
| Jan. 31, 2002 | Go Pro |
| Oct. 31, 2001 | Go Pro |
| July 31, 2001 | Go Pro |
| April 30, 2001 | Go Pro |
| Jan. 31, 2001 | Go Pro |
About Revenues
Income that a company gains from business activities, calculated before any expenses are subtracted. Includes all sales and other increases in owner's equity. Increasing revenues over time are generally a good sign of company's growth.
While a bit obvious, if a lemonade company has sold 30 million in revenue and has 10 million in costs of goods sold, the company's revenue is still 30 million. (Expenses are not accounted in Revenue).
Learn More
GNBT Revenue Quarterly Benchmarks
| Companies | |
|---|---|
| ARCA biopharma | 0.00 |
| Advanced Proteome Therpt | 0.00 |
| Clinuvel Pharmaceuticals |
GNBT Revenue Quarterly Rankings
| Overall |
50th percentile 8312 of 16773 |
| Sector |
40th percentile 833 of 1408 in Healthcare |
| Industry |
45th percentile 248 of 453 in Biotechnology |
GNBT Revenue Quarterly Range, Past 5 Years
| Minimum | 0.000 | Oct 2012 |
| Maximum | 0.5383M | Oct 2008 |
| Average | 0.1336M |
